:

SERVICENOW BEATS Q1 ESTIMATES BUT STOCK DROPS

INDUSTRY DESK1 MIN READ
WED, APR 22, 2026

■ AI-SUMMARIZED FROM 1 SOURCE ▸ TIMELINE

ServiceNow reported Q1 subscription revenue of $3.67B, slightly above the $3.65B estimate, with 22% year-over-year growth. The stock fell 12% in after-hours trading despite the beat.

The enterprise software company attributed headwinds to Middle East conflict, which impacted customer spending and delayed deals. Q1 results showed subscription revenue growth continuing at a healthy clip, though the modest margin above expectations was not enough to satisfy investors. The sharp stock decline suggests Wall Street may have been pricing in a larger beat or more bullish guidance. The geopolitical headwinds cited by management could indicate broader economic caution among enterprise customers, a potential warning sign for the sector. ServiceNow, which provides cloud-based workflow and IT service management software, has faced pressure this year as customers reassess spending priorities. The company's acknowledgment of external factors affecting growth signals it is navigating a more complex sales environment despite maintaining solid revenue momentum.

■ SOURCES

Techmeme

■ SUMMARY WRITTEN BY AI FROM THE LINKS ABOVE

■ MORE FROM THE BUSINESS DESK

The UK government has dismissed Green party leader Zack Polanski's proposal for a moratorium on large-scale AI datacentre construction, citing economic concerns over the energy and water-intensive projects.

1H AGOAI Desk

ChangXin Memory Technologies (CXMT), China's leading memory chip producer, filed a lawsuit against the Pentagon on Friday challenging its designation as a Chinese military company. CXMT denies military affiliation and claims its chips are for civilian use only.

1H AGOIndustry Desk

A US appeals court has ruled against Kalshi's attempt to block Nevada from regulating its platform, determining that the prediction market platform cannot escape state gambling laws by rebranding bets as 'swaps.'

1H AGOIndustry Desk

Vijay Pande has left Andreessen Horowitz's $4 billion biotech practice to launch VZVC, a smaller AI-native venture fund focused on transforming drug discovery through engineering principles rather than traditional discovery methods.

1H AGOIndustry Desk

■ SUBSCRIBE TO THE DAILY BRIEF

ONE EMAIL, 5 STORIES, 06:00 UTC. UNSUBSCRIBE ANYTIME.